Carimatech
A high-precision 3D printing automation company that provides advanced DLP (Digital Light Processing) solutions for smart mass production in the bio-pharmaceutical, ceramic, and industrial sectors.
- CEO / Founder
- Kwang-min Lee
- Team Size
- 8-15
- Stage
- Early commercialization / Public beta
- Total Funding
- $1.5M (Estimated)
- Latest Round
- Seed / TIPS Grant
- Key Investors
- ["FuturePlay","Ministry of SMEs and Startups (TIPS)"]
Technology & Products
Key Products
["Bio-3D Printer for Direct Slide Glass Printing (Specialized for pharmaceutical high-throughput screening)","Ceramic 3D Printing Mass Production System (Targeting defense and medical components)","X1: High-speed industrial DLP 3D printer for rapid manufacturing","DM400: Automated industrial 3D printing system designed for operator-less 24/7 production","Automated Post-processing & Curing Units"]
Technological Advantage
Leverages 33 years of digital optical expertise from its parent company, Carima, to achieve superior DLP precision while integrating smart automation that allows for continuous mass production without manual intervention.
Market & Competition
Target Customers
Pharmaceutical research institutes, biotechnology firms, defense contractors, and medical device manufacturers requiring automated high-volume production.
Industry Verticals
["Biotechnology & Pharmaceuticals","Defense & Aerospace","Medical & Dental","Industrial Manufacturing (Automotive/Mobility)"]
Competitors
["Lithoz","3DCeram","Rokit Healthcare","BICO (CELLINK)","T&R Biofab"]